A prospective randomised study comparing the outcome of bipolar enucleation of prostate with transurethral resection of prostate(TURP) and Thulium laser enucleation of prostate(ThuLEP)

Prospective randomised study comparing the outcome of Bipolar enucleation of prostate with transurethral resection of prostate (TURP)and Thulium laser enucleation of prostate(ThuLEP) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072009

Enrollment

Registered

2024-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Bipolar enucleation of prostate: Bipolar enucleation of prostate is a new surgical modality of treatment for prostatomegaly with bothersome symptoms. In this modality enlarged prosta

Eligibility

Inclusion criteria

Inclusion criteria: Bothersome LUTS with failed medical management Maximum flow rate less than 15 millilitre per second Complications secondary to BPH- recurrent hematuria of prostatic pathology Refractory urinary retention Recurrent urinary tract infection

Exclusion criteria

Exclusion criteria: Neurogenic bladder High bladder neck Diagnosed prostatic cancer

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of bipolar enucleation of prostateTimepoint: One year	—

Secondary

Measure	Time frame
Compare intraoperative , immediate postoperative and short term outcome of TURP, ThuLEP and bipolar enucleation of prostateTimepoint: One year	—

Countries

India

Contacts

Public ContactDebansu Sarkar

IPGMER

dedebanshu@gmail.com9830010826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026